Younong Xu

1.1k citations

22 papers · 877 indexed · h-index 15

Co-authors: Toshio Hattori Nobutaka Fujii Xiaoyan Zhang Frank R. Jones Elizabeth S. Gabitzsch Akane Omagari Joseph P. Balint Hideki Nakashima
Topics: HIV Research and Treatment (15 papers)Virus-based gene therapy research (8 papers)Immunotherapy and Immune Responses (7 papers)
Cited by: Virology Immunology Oncology
Journals: Journal of Clinical Oncology The Journal of Immunology PLoS ONE
Partner nations: United States Japan Belgium

In The Last Decade

Younong Xu

22 papers receiving 861 citations

Peers

Countries citing papers authored by Younong Xu

Since Specialization

Citations

This map shows the geographic impact of Younong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Younong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Younong Xu more than expected).

Fields of papers citing papers by Younong Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Younong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Younong Xu. The network helps show where Younong Xu may publish in the future.

Co-authorship network of co-authors of Younong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Younong Xu. A scholar is included among the top collaborators of Younong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Younong Xu. Younong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer 2015 ·Cancer Immunology Immunotherapy ·Joseph P. Balint,Elizabeth S. Gabitzsch,Adrian Rice,Yvette Latchman,Younong Xu,Gerald L. Messerschmidt,Arvind Chaudhry,Michael A. Morse,Frank R. Jones	37
2	Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients 2013 ·Cancer Immunology Immunotherapy ·Michael A. Morse,Arvind Chaudhry,Elizabeth S. Gabitzsch,Amy Hobeika,Takuya Osada,Timothy M. Clay,Andrea Amalfitano,Bruce K. Burnett,Gayathri R. Devi,David S. Hsu,Younong Xu,Stephanie Balcaitis,(unknown),Susan Nguyen,Joseph P. Balint,Frank R. Jones,H. Kim Lyerly	68
3	Successful Isolation of Infectious and High Titer Human Monocyte-Derived HIV-1 from Two Subjects with Discontinued Therapy 2013 ·PLoS ONE ·Tong Wang,Younong Xu,Haiying Zhu,(unknown),(unknown),(unknown),(unknown),(unknown),Michael Zhou,(unknown),Zihuan Yang,Sarah Holte,Lawrence Corey,Tuofu Zhu	14
4	Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform 2012 ·Vaccine ·Elizabeth S. Gabitzsch,(unknown),Younong Xu,Stephanie Balcaitis,Brigitte E. Sanders-Beer,Julie A. Karl,Kent J. Weinhold,Slobodan Paessler,Frank R. Jones	8
5	Induction and comparison of SIV immunity in Ad5 naïve and Ad5 immune non-human primates using an Ad5 [E1-, E2b-] based vaccine 2011 ·Vaccine ·Elizabeth S. Gabitzsch,Younong Xu,Joseph P. Balint,Stephanie Balcaitis,Brigitte E. Sanders-Beer,Frank R. Jones	17
6	Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine 2011 ·Vaccine ·Frank R. Jones,Elizabeth S. Gabitzsch,Younong Xu,Joseph P. Balint,Viktoriya Borisevich,Jennifer Smith,Jeanon N. Smith,Bi‐Hung Peng,Aida G. Walker,(unknown),Slobodan Paessler	21
7	Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA 2010 ·Cancer Immunology Immunotherapy ·Elizabeth S. Gabitzsch,Younong Xu,Joseph P. Balint,Zachary C. Hartman,H. Kim Lyerly,Frank R. Jones	39
8	Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity 2009 ·Vaccine ·Elizabeth S. Gabitzsch,Younong Xu,(unknown),Joseph P. Balint,Andrea Amalfitano,Frank R. Jones	39
9	Blood Monocytes Harbor HIV Type 1 Strains with Diversified Phenotypes Including Macrophage‐Specific CCR5 Virus 2008 ·The Journal of Infectious Diseases ·Younong Xu,Haiying Zhu,(unknown),(unknown),(unknown),(unknown),Leonidas Stamatatos,James I. Mullins,Lawrence Corey,Tuofu Zhu	32
10	A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses 2008 ·Immunology Letters ·Elizabeth S. Gabitzsch,Younong Xu,(unknown),Joseph P. Balint,Richard B. Gayle,Andrea Amalfitano,Frank R. Jones	30
11	Most Highly Exposed Seronegative Men Lack HIV-1-Specific, IFN-γ-Secreting T Cells 2003 ·The Journal of Immunology ·Florian Hladik,Anthony L. Desbien,Jean Lang,Lei Wang,Yan Ding,Sarah Holte,Aaron Wilson,Younong Xu,(unknown),(unknown),M. Juliana McElrath	47
12	Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140 2001 ·Bioorganic & Medicinal Chemistry Letters ·Hirokazu Tamamura,Akane Omagari,Kenichi Hiramatsu,Kazuyo Gotoh,Taisei Kanamoto,Younong Xu,Eiichi Kodama,Masao Matsuoka,Toshio Hattori,Naoki Yamamoto,Hideki Nakashima,(unknown),Nobutaka Fujii	98
13	The possible involvement of CXCR4 in the inhibition of HIV‐1 infection mediated by DP178/gp41 2000 ·FEBS Letters ·Younong Xu,Xiaoyan Zhang,Masao Matsuoka,Toshio Hattori	15
14	Human Monoclonal Antibody 98-6 Reacts with the Fusogenic Form of gp41 2000 ·Virology ·Yuko Taniguchi,Susan Zolla‐Pazner,Younong Xu,(unknown),Satoshi Takeda,(unknown)	12
15	Inhibition of infection of incoming HIV‐1 virus by RNA‐cleaving DNA enzyme 1999 ·FEBS Letters ·Xiao Yan Zhang,Younong Xu,Hong Ling,Toshio Hattori	42
16	Marked Increase in Anti-HIV Activity, as Well as Inhibitory Activity against HIV Entry Mediated by CXCR4, Linked to Enhancement of the Binding Ability of Tachyplesin Analogs to CXCR4 1999 ·AIDS Research and Human Retroviruses ·Younong Xu,Hirokazu Tamamura,Rieko Arakaki,(unknown),Xiaoyan Zhang,Nobutaka Fujii,Takashi Uchiyama,(unknown)	34
17	A Low-Molecular-Weight Inhibitor against the Chemokine Receptor CXCR4: A Strong Anti-HIV Peptide T140 1998 ·Biochemical and Biophysical Research Communications ·Hirokazu Tamamura,Younong Xu,Toshio Hattori,Xiaoyan Zhang,Rieko Arakaki,Kenji Kanbara,Akane Omagari,Akira Otaka,Toshiro Ibuka,Naoki Yamamoto,Hideki Nakashima,Nobutaka Fujii	264
18	Phosphorothioate Hammerhead Ribozymes Targeting a Conserved Sequence in the V3 Loop Region Inhibit HIV-1 Entry 1998 ·Antisense and Nucleic Acid Drug Development ·Xiaoyan Zhang,Yasumasa Iwatani,(unknown),Ryo Yamada,Atsushi Koito,Younong Xu,Hiroyuki Sakai,Takashi Uchiyama,Toshio Hattori	9
19	Triazine Dyes Inhibit HIV‐1 Entry by Binding to Envelope Glycoproteins 1997 ·Microbiology and Immunology ·Toshio Hattori,Xiaoyan Zhang,Carol D. Weiss,Younong Xu,Toru Kubo,Yoshimi Sato,Shigemichi Nishikawa,(unknown),Takashi Uchiyama	8
20	Characterization of V3 Loop-Binding Protein(s) of Molt-4 and U937 Cells 1995 ·AIDS Research and Human Retroviruses ·Younong Xu,Toshio Murakami,(unknown),Takashi Uchiyama,Toshio Hattori	8

About Younong Xu

Younong Xu is a scholar working on Virology, Immunology and Genetics, having authored 22 papers that have together received 877 indexed citations. Recurring topics across this work include HIV Research and Treatment (15 papers), Virus-based gene therapy research (8 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Virology (289 citations), Immunology (449 citations) and Oncology (371 citations). Younong Xu has collaborated with scholars based in United States, Japan and Belgium. Frequent co-authors include Toshio Hattori, Nobutaka Fujii, Xiaoyan Zhang, Frank R. Jones, Elizabeth S. Gabitzsch, Akane Omagari, Joseph P. Balint, Hideki Nakashima, Rieko Arakaki and Hirokazu Tamamura. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact